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In Equatorial Guinea, malaria continues to be one of the main causes of morbidity and mor-
tality among children. The National Therapeutic Guide established artesunate-amodiaquine
(ASAQ) as first-line treatment for uncomplicated malaria, but compliance with this treatment
is low. The aim of this study was to assess, for the first time, the performance of public
healthcare workers in the diagnosis and treatment of uncomplicated malaria, their compli-
ance with first-line Malaria National Therapeutic Guide and the associated factors.
Methods
A cross-sectional survey was conducted at the nine public health facilities in the Bata District
of Equatorial Guinea to assess the management of uncomplicated malaria in children < 15
years of age. Bivariate and multivariate statistical analyses were used to determine the rec-
ommended treatment compliance and related factors.
Results
A total of 227 children with uncomplicated malaria were recorded from 9 public health
facilities. Most of the treatments prescribed (83.3%) did not follow the first-line treatment rec-
ommended for uncomplicated malaria. The diagnosis was established with parasite confir-
mation in 182 cases (80.2%). After adjustment for other variables, children under 2 months
of age, the use of parasite confirmation to the diagnosis of malaria and being familiar with
the national therapeutic guide were significantly associated with the prescription of the first-
line recommended treatment. Cases attended at the hospital or in a health facility with
ASAQ in the pharmacy at the time of the study were also more likely to be prescribed with
the recommended treatment, but with non-significant association after adjustment for other
variables.







Citation: Suárez-Sánchez P, Garcı́a B, Nzang J,
Ncogo P, Riloha M, Berzosa P, et al. (2019)
Failures in the case management of children with
uncomplicated malaria in Bata district of Equatorial
Guinea and associated factors. PLoS ONE 14(8):
e0220789. https://doi.org/10.1371/journal.
pone.0220789
Editor: Thomas A. Smith, Swiss Tropical & Public
Health Institute, SWITZERLAND
Received: April 22, 2019
Accepted: July 23, 2019
Published: August 2, 2019
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Conclusions
This study identified the factors associated with the low compliance with the first-line treat-
ment by the public healthcare facilities of Bata District of Equatorial Guinea. It seems neces-
sary to improve case management of children with uncomplicated malaria; to reinforce the
use of Malaria National Therapeutic Guide and to inform about the danger of using artemisi-
nin monotherapy. Furthermore, it is crucial to provide recommended first-line treatment to
the pharmacies of all public health facilities to ensure access to this treatment.
Introduction
Malaria continues to be one of the main causes of premature death in Africa. Children < 5
years of age are the most vulnerable group, accounting for 61% of all malaria deaths [1].
Prompt diagnosis and treatment is the most effective way to prevent malaria from developing
into severe disease and death. To improve treatment efficacy and overcome drug resistance to
former antimalarial drugs, such as chloroquine (CN) and sulfadoxine-pyrimethamine (SP),
the World Health Organization (WHO) recommended the use of artemisinin-based combina-
tion therapy (ACT) as first-line treatment for uncomplicated malaria since 2001 [2].
Effective case management at public health facilities is one of the cornerstones of malaria
control [3]. Plasmodium falciparum resistance to artemisinin and its derivatives has spread in
Southeast Asia and is threatening malaria control efforts. In sub-Saharan Africa, low or inade-
quate use of artemisinin combination therapies (ACTs) may increase the malaria burden and
the risk of widespread parasite resistance [4] as presumptive treatment, co-medication, low
ACTs quality, and the use of artemisinin monotherapy persists [5]. Artemisinin monotherapy
can contribute to the emergence of resistance to ACTs and lead to treatment failure [6].
Malaria is an endemic disease in Equatorial Guinea [7]. According to the WHO, there were
an estimated 435,143 cases of malaria in 2017 in Equatorial Guinea, one of the countries with
an increase in case incidence since 2010 [1]. Malaria continues to be one of the main causes of
morbidity and mortality among children, and represents 21% of the causes of death in
children < 5 years of age [8]. Furthermore, the percentage of malaria cases treated with anti-
malarial medications in Equatorial Guinea remains lower than many other countries in the
region [1].
During recent years, national programs have adapted the WHO treatment recommenda-
tions into their local context. In Equatorial Guinea, the National Program to Malaria Control
(NPMC) of the Ministry of Health and Social Welfare (MINSABS in Spanish) updated its
Malaria National Therapeutic Guide (MNTG) in 2008, establishing ACT artesunate-amodia-
quine (ASAQ) as first-line treatment for uncomplicated malaria. The use of oral artemisinin
monotherapy was forbidden in Equatorial Guinea in 2014 [9]; however, nine years after the
introduction of ASAQ therapy in Equatorial Guinea, compliance with the first-line treatment
seems to be very poor in the Bata district. In previous studies, caregivers reported that
injectable artemether (AM) monotherapy was used as first-line treatment for uncomplicated
malaria in children in the Bata District of Equatorial Guinea, independent of where they
sought treatment [10,11]. The inadequate use of artemisinin monotherapy involves serious
risks leading to parasite resistance and disease recrudescence [12].
The compliance of healthcare workers with national treatment recommendations is funda-
mental for the success of malaria control policies but there are many problems for implemen-
tation at the healthcare provider level [13]. In many African countries, treatment compliance
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depends on a functional supply chain, beliefs established in the community, lack of knowledge
regarding treatment guidelines and the existence of a broad alternative prescribing practice
[14–18].
The aim of this study was to assess, for the first time, the diagnosis and prescription prac-
tices for uncomplicated malaria in the Bata District of the continental region in Equatorial
Guinea. The degree of compliance with the Malaria National Therapeutic Guide (MNTG) and
the associated factors were evaluated to facilitate design strategies addressed to reinforce
malaria case management.
Methods
Study design and setting
The Bata District, in the Litoral province of the continental region of Equatorial Guinea, is the
largest district of the country with a population of 309,345 inhabitants [7]. The proportion of
the population living in urban areas increased from 27.1% in 1975 to 95.3% in 2015 [19].
The public health system structure in the Bata District consists of 10 public health facilities
formed by 9 health centers and 1 regional hospital, this last one located in the city of Bata. At
the time of this study, only 8 health centers were operational (2 rural and 6 urban). Despite the
public status of the health institutions, in Bata District patients must pay for consultations,
complementary tests, and treatments. Management of the public facilities are heterogeneous
(government, NGOs, and religious congregations) with different prices, patient flow, and
availability of drugs in stock. Private pharmacies and other pharmaceutical sellers are distrib-
uted throughout the rural and urban areas of the district. There are also some private health
facilities in the Bata District, including two hospitals, and about 23 clinics, all in the urban area
of Bata city. The last prevalence of malaria rate known among children < 15 years of age was
41.2% in 2013 [20].
The Equatorial Guinea MNTG was the reference for this study, where ASAQ is the first-
line treatment recommended in all children > 2 months of age with malaria, and quinine
(QN) is recommended for younger patients. Artemether-lumefantrine (AL) and QN remains
second-line treatment when ASAQ is not effective. Intravenous artesunate is recommended
for the management of severe malaria until the patient regains consciousness, then full ASAQ
therapy should be administered. If artesunate is not available, quinine or artemether should be
administered [9].
The NPMC has implemented a set of malaria control interventions in the last 20 years in
Equatorial Guinea. A large-scale control program, the Equatorial Guinea Malaria Control Ini-
tiative (EGMCI), was launched in the continental region in 2007 to improve the malaria case
management with the distribution of free ASAQ to all health facilities. The EGMCI ceased its
activities in the region in 2011 due to a lack of funding and the National Program stopped then
the supply of antimalarial drugs to the public health facilities of the continent [7,21]. This lack
of governmental provision affected the pharmacies of all public health facilities in Bata, includ-
ing the regional hospital. Since 2012, the pharmacy managers of the public health facilities
have to purchase their own antimalarial drugs to the private distributors. From there on, each
health facility is deciding which antimalarial to acquire, following their own criteria and with-
out governmental supervision.
Study population and data collection
A cross-sectional survey was conducted, between October and December 2017, in the Bata
District of Equatorial Guinea to assess management of uncomplicated malaria in patients < 15
years of age by public healthcare practitioners. Health facility surveys and cases registration
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were carried out at all nine operative public health facilities. There were 28 physicians, 13
nurses and 3 medical assistants who attended patients in consultation in the Bata District. All
health professionals who attended patients under 15 years old with suspected malaria were
included in the study and followed up during one day of consultation. Data was systematically
collected by two trained fieldworkers in three questionnaires. The first for the cases registra-
tion, the assessment of the health worker malaria diagnosis and treatment practices: registra-
tion of the characteristics of patients diagnosed with malaria (age, weight, days with fever,
main signs and symptoms), the availability and use of malaria diagnostic tools, such as rapid
diagnostic tests (RDTs) or microscopy. This information was systematically recorded from
direct observation while accompanying each health practitioner during consultation. Measures
were taken in order to minimize the Hawthorne effect [22]. The health workers observed were
informed about the objective of the study and the anonymity of the data collected. Visits to the
same health facilities were alternated in time to reduce the pressure on the health workers and
avoid comparisons between them. Data collection for patients was also fully anonymous.
The second questionnaire was carried out for assessing the availability of ASAQ and any
other antimalarial drugs at the pharmacy. At the end of the consultation day, a third question-
naire was answered by every health worker included in the study with questions about their
sociodemographic characteristics, malaria diagnosis, their knowledge about the Malaria
National Therapeutic Guide, which antimalarial they considered as the best treatment and
other related questions. Data was doubly entered with EpiInfo 7.2 (CDC).
Data analysis
Any healthcare worker who performed consultations and prescribed antimalarial medications
to patients has been considered as a practitioner, irrespective of their professional background.
Malaria management of children with suspected malaria was recorded, but only patients diag-
nosed with uncomplicated malaria were included in the analysis.
The variable “Recommended prescription for uncomplicated malaria”, was created accord-
ing to first-line treatment of the Malaria National Treatment Guide based on the age of the
patient, as follows: QN if the child was < 2 months of age; and ASAQ for children 2 months-
to-15 years of age [9]. When the practitioner obtained a hemoglobin level, the results were cat-
egorized for analysis according to the WHO hemoglobin levels to diagnose anaemia at sea
level [23]. Finally, within the third questionnaire, the prescribers were asked about whether
they knew or not the Malaria National Treatment Guide and their answers are shown here in a
variable labelled "Knowing the MNTG".
Frequencies and percentages were used to summarize data in the descriptive analysis. Mean
and standard deviation or median and interquartile range were calculated for continuous vari-
ables that were or were not normally distributed, respectively.�2 tests were performed for
bivariate analysis of the associations between recommended treatment and independent vari-
ables. The Fisher exact test was used when any expected count was<5. Comparisons for
which p values were<0.05 were considered significant. A backward LR multivariate analysis
was performed to identify associations between recommended treatment and independent
variables with p values <0.10 on univariate analysis. Data analysis was performed using IBM
SPSS statistics 23.
Ethics statement
This study was approved by the Ministry of Health and Social Welfare of Equatorial Guinea
and the Ethics Committee of the Spanish National Health Institute, Carlos III (CEI PI
71_2017). Written informed consent was obtained from all participants in the study.
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Results
Information involving 262 patients diagnosed with malaria was registered at the 8 operational
public health centers and the regional hospital of Bata district, but 35 (12.2%) were diagnosed
with complicated malaria. Therefore, a total of 227 patients with uncomplicated malaria were
included in this study. Most of the malaria cases were children 1–5 years of age (55.1%), from
the urban area (91.63%) and with no differences between sexes. High parasitemia was found in
12.6% of the blood films.
Regarding treatment, most prescriptions observed (83.3%) did not follow the first-line
treatment MNTG recommended for uncomplicated malaria. Furthermore, 84.4% of the
patients who were eligible to receive ASAQ, received other treatment (Table 1).
Atemether was the antimalarial most prescribed among children older than five years
(54.2), while patients between 2 and 11 months mainly received the ACT artemether-lumefan-
trine (AL) as prescription (55.6%). Children <2 months were manly prescribed quinine
(42.8%) but also chloroquine (28.6%). The prescription of sulfadoxine-pyrimethamine (SP)
was recorded quite frequently (35.7%) but always as a complementary treatment. SP was pre-
scribed in a single dose mainly with intramuscular AM (80.2%) or oral AS (14.8%).
Patient-related factors
The symptoms of malaria patients were self-reported fever (94.3%), cough (47.6%), loss of
appetite (22.9%), vomiting (22.0%), and weakness (19.8%). Clinical signs of anaemia and
splenomegaly were only observed in 7.5% and 1.8% of the patients, respectively.
From 214 children reporting fever, 183 (85.5%) knew the onset day. Among those, only 44
(24.0%) sought treatment within the first 24 hours. The median duration of fever at the time of
the consultation was 2 days (IQR: 2–3). Practitioners took the axillary temperature with a ther-
mometer only in 83 cases (36.6%), presenting fever 46 (55.42%) of them. More than half of the
children 154 (61.8%) were weighed. Hemoglobin levels were measured in 107 children
(47.1%), with an average of 10.38 gr/dl (SD: 1.67); among those, 70 (65.4%) of the children
were anaemic and 42.9% had moderate anaemia. Only the age of the patients was significantly
associated with the treatment prescribed (Table 2).
Practitioners-related factors
A total of 41 practitioners were observed during medical consultations; 26 (63.4%) were at the
health centers and 15 (36.6%) at the regional hospital. Most of the practitioners were women,
<45 years of age (65.9%) with a degree career in medicine (57.7%) and a median experience of
3 years (IQR): 2–9.5) (Table 3). Practitioners established the diagnosis based on parasite con-
firmation for 182 patients (80.2%), 154 were confirmed by microscopy (84.6%) and the
remainder by RDT. The diagnosis in 19.8% of the children prescribed with antimalarial drugs
was presumptive, including 20 patients that had negative laboratory tests results.
Table 1. Treatment administered by patient age.
AS/AQ AL AS/MQ AS QN AM CN Total
Age n % n % n % n % n % n % n % n
< 2 months 0 0.00 2 28.57 0 0.00 0 0.00 3 42.86 0 0.00 2 28.57 7
2–11 months 1 2.78 20 55.56 0 0.00 0 0.00 6 16.67 9 25.00 0 0.00 36
1–5 years 27 21.60 45 36.00 1 0.80 10 8.00 0 0.00 42 33.60 0 0.00 125
5 to 15 years 7 11.86 16 27.12 0 0.00 4 6.78 0 0.00 32 54.24 0 0.00 59
AS/AQ: Artesunate-Amodiaquine; AL: Artemether-Lumenfantrine; AS/MQ: Artesunate-Mefloquine; AS:Artesunate; QN: Quinine; AM: Artemether; CN: Chloroquine
https://doi.org/10.1371/journal.pone.0220789.t001
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Older practitioners and practitioners with higher education were significantly more com-
pliant with the treatment recommended. Compliance with the MNTG was also greater among
those practitioners that made parasite confirmation for diagnosis and among those who knew
the MNTG (52.3%). No significant differences were found by practitioners’ sex.
Health facility-related factors
Regarding the characteristics of the health facilities, only two public health centers had first-
line antimalarial treatment (ASAQ) in stock at the time of the study, and two health centers
(one rural and one urban) did not have any malaria diagnostic tool (Table 4).
Table 2. Characteristics of patients and symptons by prescription.





n % n %
Sex:
Female 12 12.12 87 87.88
Male 26 20.31 102 79.69 0.101
Age group:
<2 months 3 42.86 4 57.14
2–11 months 1 2.78 35 97.22
1–5 27 21.60 98 78.40
>5 7 11.86 52 88.14 0.009
Residence
Urban area 35 16.83 173 83.17
Rural area 3 20.00 12 80.00
Another district 0 0.00 4 100.00 0.631
Clinical signs and symptoms
Fever 37 17.29 177 82.71 0.701
Cough 21 19.44 87 80.56 0.298
Loss of appetite 9 17.31 43 82.69 0.901
Vomits 5 10.00 45 90.00 0.148
Weakness 5 11.11 40 88.89 0.259
Anemia 5 29.41 12 70.59 0.172
Splenomegaly 2 50.00 2 50.00 0.131
Diarrhoea 6 25.00 18 75.00 0.253
Weight (n = 154)�
<4.5 kg 0 0.00 2 100.00
4.5–8 kg 0 0.00 23 100.00
9–17 kg 17 20.48 66 79.52
18–35 kg 5 13.89 31 86.11
>35 kg 0 0.00 10 100.00 0.077
Haemoglobin levels (n = 107)�
No anaemia 6 16.22 31 83.78
Mild anaemia 2 8.70 21 91.30
Moderate anaemia 9 19.57 37 80.43
Severe anaemia 0 0.00 1 100.00 0.671
�Data of those in which the prescriber has measured this information
https://doi.org/10.1371/journal.pone.0220789.t002
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There were no significant differences in compliance of the recommended malaria treatment
regarding the type of health facility but ASAQ was more frequently prescribed at the regional
hospital. Despite the fact that 69.2% of children consulted in health facilities with ASAQ in
stock were not prescribed with this treatment, ASAQ was significantly more frequently pre-
scribed in health facilities where the treatment was available (Table 5).




n % n %
Sex:
Female 28 18.79 121 81.21
Male 10 12.82 68 87.18 0.252
Age group:
26–35 15 16.85 74 83.15
36–45 7 8.33 77 91.67
>45 16 29.63 38 70.37 0.005
Finished studies:
Medicine degree 29 22.14 102 77.86
Nursing degree 5 22.73 17 77.27
Nursing diploma 3 5.17 55 94.83
Medical assistant 1 6.25 15 93.75 0.017
Years of experience
0–3 years 21 18.75 91 81.25
>3 years 17 14.78 98 85.22 0.423
Diagnosis based on:
Presumptive diagnosis 3 6.67 42 93.33
Parasite confirmation 35 19.23 147 80.77 0.055
MNTG knowledge
No 7 6.31 104 93.69
Yes 31 26.72 85 73.28 <0.001
https://doi.org/10.1371/journal.pone.0220789.t003
Table 4. Description of public healthcare facilities in the Bata District.
Health institution Availability of diagnostic tool ASAQ in stock�� Uncomplicated
malaria cases visited during the period of the studyRapid Diagnostic Test Working microscopy
SOS Aldeas Infantiles + + - 39
M.a Gay + + + 23
M.a Rafols - + - 40
La libertad - + - 25
Ukomba + + + 16
Rı́o Campo� - - - 2
Oyarregui - - - 9
Machinda� + + - 11
Regional Hospital - + - 62
Total 4 7 2 227
�Rural Health Centers
��Available in pharmacy of the health institution at the moment of the study
https://doi.org/10.1371/journal.pone.0220789.t004
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Factors associated with MNTG treatment compliance
Based on multiple logistic regression analysis, children <2 months of age were 6 times more
likely to be prescribed with the first-line recommended treatment. Regarding case manage-
ment, those practitioners that used parasite confirmation to establish the diagnosis of malaria
were almost 6 times more likely to prescribe recommended treatment, and the practitioners
familiar with the MNTG were almost 3 times more likely to follow the MNTG. Practitioners
working at the hospital or in a health facility with ASAQ in the pharmacy at the time of the
study, were also more likely to prescribe the recommended treatment, but with a marginally
non-significant association after adjustment for other variables (Table 6).
Discussion
Most uncomplicated malaria cases in the Bata District were diagnosed based on parasite con-
firmation, but prescribed without following the first-line treatment recommended in the
MNTG. Low compliance with national protocols by healthcare workers remains a serious
problem in many countries in sub-Saharan Africa [24,25].
This lack of compliance with the national protocol has been described in many other coun-
tries in the region [15,16,25,26]. However, the use of injectable AM as first-line of treatment
for malaria is not common in the region. A similar frequent use of AM or injectable QN to
treat children with uncomplicated malaria has only been described in Sudan [15,27]. Injectable
drugs are often demanded because they are perceived to be a more effective treatment [28,29].
These practices were found to be imbedded in a sociocultural base to respond to the social
expectations of the community that demanded injectable medications and wanted prompt
recovery [30]. As AM rapidly eliminates asexual parasite stages and early sexual forms of fal-
ciparum malaria, it produces a rapid clinical and parasite response [31].
In the district of Bata most of the children were not prescribed ASAQ as treatment, even
when the antimalarial was available at the health facility’s pharmacy. The low use of the first-
line recommended treatment might be related to the perception about the side effects of this
ACT [32]. These predispositions about ASAQ might also explain the frequent use of AL in
Bata as first-line treatment for uncomplicated malaria. Beliefs by healthcare workers about a
medication could greatly influence the prescription patterns [33]. The highest prescription of
AL versus ASAQ is supporting the necessity to discuss changing the MNTG and establishing
AL as first-line treatment, if the ongoing study about therapeutic efficacy of AL versus ASAQ
would allow it.
Moreover, some of the prescriptions found in this study have not been described elsewhere.
The frequent prescription of injectable AM plus a single dose of oral SP is a combination that




n % n %
Clinic type
Regional hospital 15 24.19 47 75.81
Health center 23 13.94 142 86.06 0.065
ASAQ in stock�
No 26 13.83 162 86.17
Yes 12 30.77 27 69.23 0.010
�Available in pharmacy of the health institution at the moment of the study
https://doi.org/10.1371/journal.pone.0220789.t005
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is not included in the MNTG or in any WHO anti-malarial treatment recommendations. The
inadequate use of injectable AM as first-line treatment could promote the development of arte-
misinin derivative resistance and lead to ACT treatment failure [34,35]. While SP is the medi-
cation reserved for the Intermittent Preventive Treatment (IPT) of malaria in pregnant
women in Equatorial Guinea [9], and its frequent use as treatment may compromise the effi-
cacy of this important preventive therapy [36,37].
According to the MNTG, intravenous artesunate is recommended for the management of
severe malaria until the patient regains consciousness, then full ASAQ therapy should be adminis-
tered. Prescribing artemether injection has not justification in cases of uncomplicated malaria
even when first-line treatment was not available. Receiving injectable AM as first-line treatment
in the Bata District was found associated, in previous studies, with symptoms like nausea and
weakness, but not with any other important symptom related to the severity of the patients [11].
Previous studies showed how inappropriate prescription practices are also extended to the
private health sector and pharmaceutical sellers [10]. This situation is generating a treatment
market that seems to be based more on profitability than in public health criteria [38], espe-
cially when artemether is more expensive than AS/AQ in Bata district [11]. There is an urgent
need to improve malaria treatment practices in the public and private health sectors in Equato-
rial Guinea.
The MINSABS should ensure that first-line ACT is delivered on time to all health facilities,
which does not happen in the continental region of Equatorial Guinea since 2012 [21]. The
pharmacy managers of the public health facilities have to purchase their own antimalarial
drugs from private distributors, and consequently they could acquire the ACT desired.
Table 6. Analysis of factors associated with recommended prescription according to MNTG.
Unadjusted OR (95% CI) P value Adjusted OR (95% CI) P value
Patient age
< 2months 1 1 -
2 months—15 years 0.25 (0.05–1.18) 0.094 0.16 (0,03–0,95) 0.044
Prescriber Age
26–35 1 1 0.058
36–45 0.45 (0.17–1.16) 0.099 0.63 (0,21–1,84) 0.396
>45 2.08 (0.93–4.65) 0.075 2.36 (0,85–6,54) 0.097
Prescriber Studies
Other studies 1 - - -
Medicine degree 2.75 (1.23–6.12) 0.013 - - -
Diagnosis based on
Presumptive diagnosis 1 1
Parasite confirmation 3.33 (0.98–11.38) 0.055 5.56 (1,40–22,14) 0.015
MNTG Knowledge
No 1 1
Yes 5.42 (2,27–12,92) <0,001 2.92 (1,12–7,63) 0.029
Clinic type
Health Center 1 1
Regional Hospital 1.97 (0.95–4.09) 0.068 2.55 (0,92–7,08) 0.072
ASAQ in stock�
No 1 1
Yes 2.77 (1.25–6.14) 0.012 2.72 (0,96–7,70) 0.059
�Available in pharmacy of the health institution at the moment of the study
https://doi.org/10.1371/journal.pone.0220789.t006
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Therefore, the presence or absence of ASAQ at the health facility pharmacies could also be
related to the preferences of practitioners based on prescriptions. Only two health facilities had
ASAQ in stock at the time of the study, but most of the children diagnosed as uncomplicated
malaria in those facilities were not prescribed the recommended treatment. As in other coun-
tries, the presence of stock alone does not ensure that treatment guidelines are followed [18].
More pharmacy management research is needed to understand the role of ASAQ stock-outs
on practitioner prescribing behavior.
Adequate malaria case management reduces progression to severe stages, and therefore
affects the morbidity and mortality rates [39]. The availability of malaria diagnostic tools in
public health facilities was higher in Equatorial Guinea than other countries in the region,
[17]; however, presumptive diagnosis, even when diagnostic tools were available, still occurs in
the Bata District in almost 20% of cases. Treatment under a presumptive diagnosis in an
endemic area implies a lower diagnostic specificity and administration of unnecessary antima-
larial therapies [40], but also underdiagnoses of other severe diseases that present with fevers
[41]. Even when the presumptive diagnosis is lower in Equatorial Guinea than other countries
in the region [4,17], it is still necessary to reinforce the importance of administering antimalar-
ial therapies with diagnostic confirmation.
Despite knowledge not always implies better dosage and therapeutic management [30], in
the Bata District practitioners who knew the therapeutic guide were three times more likely to
prescribe recommended treatment. In addition, there is an important association between
good practices and the compliance with first-line treatment. Practitioners who rely on parasite
confirmation for malaria diagnosis were almost six times more likely to prescribe MNTG
treatment. The ACTs and new therapeutic guide were introduced in the continental region of
Equatorial Guinea in 2008. Since then, no additional training has been offered to healthcare
professionals. There is an urgent need to implement new healthcare worker training in the
management of malaria cases, but also post-training follow-up and structured supportive
supervision that could guarantee changes in practice [17,42].
The main limitation of this study was the possible Hawthorne effect, resulting in a modifi-
cation of behavior on the part of the prescribers due to the presence of the research team dur-
ing the clinic consultation and therefore their compliance with the national protocol could be
even lower. Finally, this was a cross-sectional study in the Bata District, so the results may not
be generalizable to the rest of the country, even when low compliance with first-line malaria
treatment throughout the country is one of the NPMC main concerns.
Conclusions
This study identified the factors associated with the low compliance with the first-line malaria
treatment by the public healthcare facilities of Bata District of Equatorial Guinea. According with
results, it seems necessary to improve case malaria management of children with uncomplicated
malaria starting by reinforcing the use of Malaria National Therapeutic Guide and informing
about the danger of using artemisinin monotherapy. Furthermore, it is crucial to provide recom-
mended first-line treatment to the pharmacies of all public health facilities to ensure access to this
treatment and avoid possible free choices in the procurement of antimalarial drugs. It seems also
necessary to strength the diagnostic capacity of practitioners, their management of malaria symp-
toms, and the relevance to base their malaria diagnosis on parasite confirmation.
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